| A Phase Ib/II Study of BM230 in Combination With PD-1 Inhibitor for HER2-related Advanced Solid Tumors (NCT07698587) | Suzhou Biomissile Pharmaceuticals Co., Ltd. | 2026-07-01 |
| Comparing Intravenous or Intradermal Administration of Anti-CTLA-4 in Combination With Anti-PD1 Treatment in Patients With Melanoma (NCT07615881) | Amsterdam UMC, location VUmc | 2026-07-01 |
| CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) (NCT07576699) | Cellenkos, Inc. | 2026-07-01 |
| CAN1012 in Pre-malignant Oral Dysplasia (NCT07620496) | Providence Health & Services | 2026-07-01 |
| A Study Comparing a Pre-filled Safety Syringe and an Autoinjector for SHR-1703 Injection in Healthy Participants (NCT07701239) | Guangdong Hengrui Pharmaceutical Co., Ltd | 2026-07-01 |
| Pharmacokinetic and Safety Study of HYR-PB21 vs Bupivacaine Hydrochloric Acid in Healthy Participants (NCT07717086) | Fruithy Holdings Limited | 2026-07-01 |
| Preoperative Proton Irradiation for High-grade Brain Gliomas. (NCT07710040) | National Medical Research Radiological Centre of the Ministry of Health of Russia | 2026-07-01 |
| A Study of SI-B036 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors (NCT07678970) | Sichuan Baili Pharmaceutical Co., Ltd. | 2026-07-01 |
| A Study to Investigate the Safety, Tolerability, and PK of AB102 in Healthy Participants (NCT07662057) | Arcus Biosciences, Inc. | 2026-07-01 |
| A Multicenter, Prospective, Randomized, Open-label Phase Ib/II Study of Celecoxib Plus Pembrolizumab and Gemcitabine/Cisplatin Versus Pembrolizumab and Gemcitabine/Cisplatin in Patients With CK5/6-High Unresectable Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma (NCT07632235) | Shanghai 6th People's Hospital | 2026-07-01 |
| Time Restricted Eating in Patients With Microalbuminuria (NCT06884059) | University of California, San Diego | 2026-07-01 |
| Stimulation-based Therapy to Improve Balance in DCM (NCT07298460) | Medical College of Wisconsin | 2026-07-01 |
| A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS (NCT06906471) | Antelope Surgical Solutions, Inc | 2026-07-01 |
| Psilocybin Efficacy With or Without Pimavanserin Pretreatment (NCT07610135) | Johns Hopkins University | 2026-07-01 |
| Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease (NCT06647277) | ProgenaBiome | 2026-07-01 |
| Role of Medication in Making Urine Less Acidic as Part of Kidney Stone Prevention (NCT06819111) | University of Texas Southwestern Medical Center | 2026-07-01 |
| Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2). (NCT07684560) | AlphaMol Science Ltd. (Shanghai) | 2026-07-01 |
| A Phase 1, Double-blind, Randomized Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Single Dose and Multiple Doses of CG-0416 in Healthy Participants. (NCT07724431) | HongKong Curegene Innovation Co., Limited | 2026-07-01 |
| Topical Carboxytherapy Paste Following Microneedling (NCT07431541) | Vanderbilt University Medical Center | 2026-07-01 |
| A Study of [177Lu]Lu-A9-0631 and [225Ac]Ac-A9-0642 With [68Ga]Ga-A9-6217 or [177Lu]Lu-A9-0631 Imaging in GRPR+ Solid Tumors (NCT07661641) | Alpha-9 Oncology USA Inc. | 2026-07-01 |
| CD318-targeted CAR-T Cell Therapy in Patients With Pancreatic Cancer (ResCPa) (NCT07153289) | University Hospital Tuebingen | 2026-07-01 |
| Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia (NCT07439211) | Jacqueline Garcia, MD | 2026-07-01 |
| A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D (NCT07702890) | Gubra A/S | 2026-07-01 |
| Safety and Dose-Response of Bletilla Formosana in Prediabetic Subjects (NCT07704944) | Chang Gung Memorial Hospital | 2026-07-01 |
| Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma (NCT07529808) | BigHat Biosciences, Inc. | 2026-07-01 |
| An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers (NCT07426757) | Pfizer | 2026-07-01 |
| A Clinical Study of SHR-4685 on Safety, Tolerability and Pharmacokinetics in Participants With Solid Tumors (NCT07676903) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2026-07-01 |
| A Clinical Study of TQB2930 Injection and Chemotherapy With or Without Bevacizumab in the Treatment of Advanced Colorectal Cancer (NCT07653685) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2026-07-01 |
| Safety, Tolerability, and Efficacy of CP-PCA07 in Combination With Enzalutamide in Patients With Castration-Resistant Prostate Cancer (NCT07683013) | Hyundai Bioscience Co., Ltd. | 2026-07-01 |
| MSC-Exosome Therapy for Frontotemporal Dementia (NCT07638813) | Ruijin Hospital | 2026-07-01 |
| Valproate for the Treatment of Residual Amblyopia (NCT07226141) | Boston Children's Hospital | 2026-07-01 |
| Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma (NCT07365839) | Virginia Commonwealth University | 2026-07-01 |
| Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's Disease (NCT07651319) | The Methodist Hospital Research Institute | 2026-07-01 |
| A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects (NCT07452692) | Corium Innovations, Inc. | 2026-07-01 |
| Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy (NCT07172971) | Vanderbilt University Medical Center | 2026-07-01 |
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease (NCT06935474) | AbelZeta Inc. | 2026-07-01 |
| Safety and Immunogenicity of a Recombinant Poliomyelitis Vaccine (rPV) in Comparison With IPOL Vaccine in Healthy Adults (NCT07688369) | Serum Institute of India Pvt. Ltd. | 2026-07-01 |
| Bioequivalence Study of GZR4 Injection With Different Manufacturing Processes in Healthy Adult Participants (NCT07670897) | Gan & Lee Pharmaceuticals. | 2026-07-01 |
| Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant (NCT07430059) | Vivani Medical, Inc | 2026-07-01 |
| A Feasibility Study of Supplemental Oxygen to Improve Pulmonary Hypertension in People With Intradialytic Hypoxemia (NCT06327373) | Duke University | 2026-07-01 |
| Dinutuximab-beta and Chemotherapy in Newly Diagnosed High-Risk Neuroblastoma (NCT07688252) | Chang Gung Memorial Hospital | 2026-07-01 |
| CD45RA-depleted DLI for the Prevention of Viral Infections in High-risk Patients After Haploidentical Transplantation (NCT07672964) | Ruijin Hospital | 2026-07-01 |
| BPI-361175 Tablets in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT05393466) | Xcovery Holdings, Inc. | 2026-07-01 |
| BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder (NCT07596212) | University of Illinois at Chicago | 2026-07-01 |
| Pilot Studies Blocking Injury-Induced MVP Release in Skin Using Topical Amitriptyline (NCT07716722) | Wright State University | 2026-07-01 |
| A Clinical Trial to Evaluate the Bioequivalence of AD-116A and AD-1161 Under Fed Conditions in Healthy Adult Male Volunteers (NCT07722871) | Addpharma Inc. | 2026-07-01 |
| A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT07581184) | Aktis Oncology, Inc. | 2026-07-01 |
| A Study of CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101) (NCT07650357) | Clasp Therapeutics, Inc. | 2026-07-01 |
| Phase 1B Trial of Intratumoral Cisplatin for Stage IV Lung Cancer (NCT07495098) | University of Vermont | 2026-07-01 |
| A PHASE IB/II STUDY TO EVALUATE SAFETY AND EFFICACY OF BEXMARILIMAB IN COMBINATION WITH DOXORUBICIN IN METASTATIC SOFT-TISSUE SARCOMA (NCT07460986) | MedSIR | 2026-07-01 |
| CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study) (NCT07443137) | Stanford University | 2026-07-01 |
| A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma (NCT07604285) | Myosin Therapeutics Inc. | 2026-07-01 |
| Safety and Preliminary Efficacy of Endoscopic Submucosal Injection of Hyaluronic Acid Into the Bladder Wall in Patients With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) (NCT07658118) | Sverdlovsk Regional Clinical Hospital No.1 | 2026-07-01 |
| A Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants (NCT06506175) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2026-07-01 |
| A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH) (NCT07732400) | Kriya Therapeutics, Inc. | 2026-07-01 |
| Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis (NCT04585711) | Duke University | 2026-07-01 |
| A Clinical Study of MK-7262 and Enlicitide in Healthy Participants (MK-7262-003) (NCT07619443) | Merck Sharp & Dohme LLC | 2026-07-01 |
| Blackcurrants Modify Gut Microbiota and Reduce Osteoporosis Risk in Postmenopausal Females (NCT07365514) | University of Connecticut | 2026-07-01 |
| Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT07460765) | Vanderbilt-Ingram Cancer Center | 2026-07-01 |
| A Prospective, Open-Label Study Evaluating the Effectiveness of Gepants for Acute Treatment of Migraine in the Emergency Department (NCT07667621) | University of South Florida | 2026-07-01 |
| IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Newly Diagnosed and Recurrent Pediatric High-grade Glioma (pHGG) and Newly Diagnosed Diffuse Intrinsic Pontine Glioma (ndDIPG) (NCT06946680) | University of Florida | 2026-07-01 |
| Study of ChoironeX GalKO Porcine Thymokidney Xenotransplantation in End-Stage Renal Disease (NCT07696962) | Xeno Holdings (US), LLC dba ChoironeX | 2026-07-01 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics and the Effect of Food on the Hemay5259 Sustained-release Tablets in Healthy Subjects. (NCT07703904) | Hemay Pharmaceutical PTY. LTD. | 2026-07-01 |
| IL-8 Receptor Modified Patient-Derived Activated CD70 CAR T Cell Therapy in Adults With Brain Metastases (NCT07569263) | University of Florida | 2026-07-01 |
| Low Intensity Focused Ultrasound in ASD (NCT07225322) | Medical University of South Carolina | 2026-07-01 |
| A Surgical Procedure (Total Pancreatectomy) With a Transplant Procedure (Islet Cell Autotransplantation) for the Treatment of Chronic Pancreatitis and Benign Pancreatic Tumors (NCT05453851) | OHSU Knight Cancer Institute | 2026-07-01 |
| Effect of Insulin Lowering on Lipogenesis (NCT07403604) | Columbia University | 2026-07-01 |
| Safety, PK, and PD Comparison of UI059 and UIC202201 in Healthy Volunteers (NCT07727629) | Korea United Pharm. Inc. | 2026-07-01 |
| A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers (NCT07682948) | Korea United Pharm. Inc. | 2026-07-01 |
| Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cell Therapy in Diabetic Nephropathy Patients: A Clinical Trial (NCT07396155) | PT. Prodia Stem Cell Indonesia | 2026-07-01 |
| A PET/MRI Study of Cobenfy on Dopamine Transmission in Schizophrenia (NCT07423546) | New York State Psychiatric Institute | 2026-07-01 |
| The Food Effect on Pharmacokinetics of Fixed Dose Combination of Gemigliptin/Dapagliflozin/Metformin in Healthy Volunteers (NCT07396844) | LG Chem | 2026-07-01 |
| Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients (NCT07614646) | Everest Medicines (Beijing) Co., Ltd. | 2026-07-01 |
| Phase 1 Study of WBRT or PCSI With REYOBIQ for Leptomeningeal Metastases (NCT07674693) | NYU Langone Health | 2026-07-01 |
| HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion (NCT07699757) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| Safety and Efficacy of Allogeneic Bone Marrow MSCs in Ankylosing Spondylitis (NCT07632599) | Eighth Affiliated Hospital, Sun Yat-sen University | 2026-07-01 |
| Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II (NCT07131722) | PRG Science & Technology Co., Ltd. | 2026-07-01 |
| CIB In Vivo CAR-T Lentiviral Injection in Patients With Advanced Malignant Tumors (NCT07657585) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-07-01 |
| Adding Effect of Cross-linked Hyaluronic Acid to Microneedling After Coronally Advanced Flap in Isolated RT1 Recession (NCT07520539) | Cairo University | 2026-07-01 |
| Study of LT-010391 in Participants With KRAS G12D-Mutant Solid Tumors (NCT07624214) | Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. | 2026-07-01 |
| HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation (NCT06918665) | Murdoch Childrens Research Institute | 2026-07-01 |
| Randomized Double-blind Controlled Clinical Study of SGLT-2i Combined With Probiotic Preparations in Elderly Patients With HFpEF (NCT07687212) | The First Affiliated Hospital of Air Force Medicial University | 2026-07-01 |
| Renal Impairment Study for Oral EC5026 (NCT07694544) | EicOsis Human Health Inc. | 2026-07-01 |
| High-Protein Diet for Improving Alcoholic Fatty Liver Disease (NCT07632222) | Li Lab,MD | 2026-07-01 |
| A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer (NCT07543471) | Shanghai Henlius Biotech | 2026-06-30 |
| A Multicenter, Open-label, Non-randomized, Single-arm Phase 1/2 Study of Autologous Nano CD5-CAR T Cells for the Treatment of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma (NCT07678307) | Institute of Hematology & Blood Diseases Hospital, China | 2026-06-30 |
| A Study of IBI3031 in Participants With Thyroid Eye Disease (NCT07622368) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-06-30 |
| VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations (NCT07629089) | Megan Mantica | 2026-06-30 |
| To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer (NCT07647744) | Hrain Biotechnology Co., Ltd. | 2026-06-30 |
| A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) (NCT07564596) | Climb Bio, Inc. | 2026-06-30 |
| A Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells for Acute Ischemic Stroke (NCT07628933) | BOE Technology Group Co., Ltd. | 2026-06-30 |
| Phase 1 Study of HS-10541 as Monotherapy or in Combination With Other Anti-cancer Therapies in Patients With KRAS G12C Mutation Advanced Solid Tumors. (NCT07615413) | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 2026-06-30 |
| A Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Pharmacodynamics, and Efficacy of P-CD19CD20-ALLO1 in Participants With Severe, Treatment-refractory Systemic Lupus Erythematosus (SLE) (NCT06984341) | Genentech, Inc. | 2026-06-30 |
| A Study of IPM514 in Patients With Esophageal Squamous Cell Carcinoma. (NCT07203898) | Beijing Immupeutics Medicine Technology Limited | 2026-06-30 |
| Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab (NCT07751042) | Strand Therapeutics Inc. | 2026-06-30 |
| A Study on the Effect of Food and Proton Pump Inhibitor on the Pharmacokinetics of HMPL-760 Capsules (NCT07643272) | Hutchmed | 2026-06-30 |
| SAD Study of CGB3002 in Healthy Participants (NCT07660341) | ChainGen Biopharma Ltd | 2026-06-30 |
| IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis (NCT06677710) | Indapta Therapeutics, INC. | 2026-06-30 |
| SCTB41 Plus SCTB39G With or Without Standard Therapy in Advanced Solid Tumors (NCT07665970) | Sinocelltech Ltd. | 2026-06-30 |
| Safety and Activity of HF50 in Patients With Advanced Solid Tumors (NCT07601334) | HighField Biopharmaceuticals Corporation | 2026-06-30 |